Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz, Schubertstraße 1, A-8010 Graz, Austria.
Institute for Chemistry and Technology of Materials (ICTM), Graz University of Technology, Stremayrgasse 9, A-8010 Graz, Austria.
Bioorg Med Chem. 2019 May 15;27(10):2052-2065. doi: 10.1016/j.bmc.2019.03.061. Epub 2019 Apr 2.
The substitution of 6-fluoroquinolines was modified in ring positions 2 and 4. The new compounds were tested in vitro for their activities against a sensitive and a multidrug resistant strain of Plasmodium falciparum. Some physicochemical parametres were calculated (log P, log D, ligand efficiency) or determined experimentally (permeability). The most promising compounds were tested for their in vivo activity against Plasmodium berghei in a mouse model. The 6-fluoro-2-{4-[(4-methylpiperazin-1-yl)methyl]phenyl}-N-[2-(pyrrolidin-1-yl)ethyl]quinoline-4-carboxamide possessed proper physicochemical properties and showed high antiplasmodial activity in vitro (IC ≤ 0.0029 µM) and in vivo (99.6% activity).
6-氟喹啉的取代发生在环的 2 位和 4 位。新化合物在体外对敏感和多药耐药的恶性疟原虫进行了活性测试。计算了一些物理化学参数(log P、log D、配体效率)或通过实验测定(渗透性)。最有前途的化合物在小鼠模型中进行了体内抗疟原虫伯氏疟原虫活性测试。6-氟-2-{4-[(4-甲基哌嗪-1-基)甲基]苯基}-N-[2-(吡咯烷-1-基)乙基]喹啉-4-甲酰胺具有适当的物理化学性质,在体外(IC ≤ 0.0029 µM)和体内(99.6%的活性)具有高抗疟原虫活性。